Cardinal Health Inc (CAH) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Cardinal Health Inc stock (CAH) is currently trading at $211.31. Cardinal Health Inc PE ratio is 29.77. Cardinal Health Inc PS ratio (Price-to-Sales) is 0.20. Analyst consensus price target for CAH is $249.60. WallStSmart rates CAH as Underperform.
- CAH PE ratio analysis and historical PE chart
- CAH PS ratio (Price-to-Sales) history and trend
- CAH intrinsic value — DCF, Graham Number, EPV models
- CAH stock price prediction 2025 2026 2027 2028 2029 2030
- CAH fair value vs current price
- CAH insider transactions and insider buying
- Is CAH undervalued or overvalued?
- Cardinal Health Inc financial analysis — revenue, earnings, cash flow
- CAH Piotroski F-Score and Altman Z-Score
- CAH analyst price target and Smart Rating
Cardinal Health Inc
📊 No data available
Try selecting a different time range
CAH Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Cardinal Health Inc (CAH)
CAH is trading near its Graham intrinsic value of $263.37, suggesting the stock is reasonably priced at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

Smart Analysis
Cardinal Health Inc (CAH) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in market cap, peg ratio, price/sales. Concerns around operating margin and price/book. Fundamentals are solid but monitor weak areas for improvement.
Cardinal Health Inc (CAH) Key Strengths (4)
Paying less than $1 for every $1 of annual revenue
90.50% of shares held by major funds and institutions
Large-cap company with substantial market presence
Good growth relative to its price
Supporting Valuation Data
Cardinal Health Inc (CAH) Areas to Watch (5)
Near-zero operating margins, business under pressure
Very expensive at 16.1x book value
Very thin margins, barely profitable
Solid revenue growth at 18.80% per year
Solid earnings growth at 19.40%
Supporting Valuation Data
Cardinal Health Inc (CAH) Detailed Analysis Report
Overall Assessment
This company scores 52/100 in our Smart Analysis, earning a C- grade. Out of 9 metrics analyzed, 4 register as strengths (avg 9.3/10) while 5 fall into concern territory (avg 3.4/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales, Institutional Own., Market Cap. Valuation metrics including PEG Ratio (1.33), Price/Sales (0.20) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Operating Margin, Price/Book, Profit Margin. Some valuation metrics including Price/Book (16.07) suggest expensive pricing. Growth concerns include Revenue Growth at 18.80%, EPS Growth at 19.40%, which may limit upside. Profitability pressure is visible in Operating Margin at 1.23%, Profit Margin at 0.68%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at 1.23% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 18.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (Price/Sales, Institutional Own.) and negatives (Operating Margin, Price/Book). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
CAH Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
CAH's Price-to-Sales ratio of 0.20x sits near its historical average of 0.2x (56th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 43% below its historical high of 0.35x set in Mar 2007, and 121% above its historical low of 0.09x in Jan 2019.
WallStSmart Analysis Synopsis
Data-driven financial summary for Cardinal Health Inc (CAH) · HEALTHCARE › MEDICAL DISTRIBUTION
The Big Picture
Cardinal Health Inc is a strong growth company balancing expansion with improving profitability. Revenue reached 244.7B with 19% growth year-over-year. Profit margins are strong at 68.0%, reflecting pricing power and operational efficiency.
Key Findings
Profit margin of 68.0% and operating margin of 123.0% demonstrate strong pricing power and operational efficiency.
Generating 555M in free cash flow and 686M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Sector dynamics: monitor MEDICAL DISTRIBUTION industry trends, competitive moves, and regulatory changes that could impact Cardinal Health Inc.
Bottom Line
Cardinal Health Inc offers an attractive blend of growth (19% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Cardinal Health Inc(CAH)
NYSE
HEALTHCARE
MEDICAL DISTRIBUTION
USA
Cardinal Health, Inc. is an American multinational health care services company.